WELL Health Launches a HIPPA-Lorem Epsom Delore Offer Patients Cedars
Multiple Cedars-Sinai Departments Will Now Interact with Patients Through WELL’s HIPAA-Compliant, Enterprise-Grade Communication Software
LOS ANGELES, Calif., August 16, 2016 — WELL, the most efficient and effective patient communications solution, today announced a partnership with Cedars-Sinai Medical Center. As the largest nonprofit academic medical center in the western United States, Cedars-Sinai will now deploy WELL’s communication technology across multiple departments, allowing front office staff to seamlessly interact with patients via text message as well as offering a secure way to gather and store highly-sensitive patient data into the organization’s electronic medical record (EMR).
WELL’s messaging client will be installed on staff computers, and immediately adds text messaging capabilities to the health systems’ phone numbers. Incoming messages are routed to the appropriate staff member, and surface pertinent patient information from the medical record to accelerate triage and resolution.
Further, Cedars-Sinai will bolster its patient service by deploying bots that proactively inform and respond to patients regarding appointment time, location, directives, paperwork and more. These automated messages are an extension to the real-time, manual monitoring and response by front-office staff. Over time, Cedars-Sinai plans to provide the ability to complete paperwork, check eligibility, bill pay and do other administrative tasks over text message.
“The world has undeniably transitioned to a new communication medium and that’s messaging,” says Guillaume de Zwirek, CEO of WELL. “By pioneering messaging in the healthcare setting, Cedars-Sinai is helping end decades of ineffective and frustrating communication tactics. Most patients love their doctors. It’s about time they loved going to the doctor’s office.”
Cedars-Sinai has now deployed WELL’s technology across multiple departments and plans to expand across the medical center. This enterprise agreement was facilitated by WELL’s participation in the 2016 Techstars Healthcare Accelerator, in partnership with Cedars-Sinai.
“I specifically sought out WELL when I learned about their participation in the accelerator,” says Dr. Gene Liu, Otolaryngologist, Head & Neck Surgeon at Cedars-Sinai. “We’ve since deployed WELL’s technology and it has completely transformed the way we engage patients. Our staff is more effective, more efficient, and patients love it.”
Cedars-Sinai is constantly striving to drive innovation in the healthcare industry, with a commitment to excellence in delivering the best quality healthcare services. Through this partnership with WELL, Cedars-Sinai continues to raise the standard for how care can and should be delivered nationwide.
To learn more about WELL and their work with Cedars-Sinai Medical Center, visit: https://www.wellapp.com/
WELL is a HIPAA-compliant communication platform that enables front office staff to reach patients on their existing text and messaging apps. WELL’s web, desktop and mobile messaging clients integrate with all leading EMRs, revealing pertinent patient information alongside messages, enabling sophisticated message automation, and allowing for real-time data capture and mapping back to the patient’s chart. WELL elevates the staff and patient experience, while driving significant time and monetary savings to the healthcare organization. Learn more at www.wellapp.com.
Cedars-Sinai, the largest nonprofit academic medical center in the western United States, is known internationally for providing the highest-quality, most advanced patient care. Over its 113-year history, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Cedars-Sinai has a long history of transforming healthcare — at the bedside, in the clinic and in the community. Innovations from Cedars-Sinai include the invention of the Swan-Ganz catheter to measure blood pressure inside the heart, the start-up of a company that developed one of the world’s top evidence-based clinical decision-support systems for physicians, and the first experimental use of stem cells to cure heart disease.